Stockreport

NeuroSense and Genetika+ Initiate Precision Medicine Collaboration Beginning with Ongoing Phase 2 Clinical Trial in Alzheimer's Disease [Yahoo! Finance]

NeuroSense Therapeutics Ltd.  (NRSN) 
PDF for severe neurodegenerative diseases announced today a collaboration in Alzheimer's Disease (AD) drug development with Genetika+ , a leader in precision medicine for ps [Read more]